Suchergebnisse - "Otto-Knapp, Ralf"

PubPharm (24)

1

Availability of drugs for the treatment of multidrug-resistant/rifampicin-resistant tuberculosis in the World Health Organization European Region, October 2023

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2024

von Otto-Knapp, R. | Edwards, S. | Kuchukhidze, G. | +4

2

Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline : Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP)

enthalten in: Pneumologie (Stuttgart, Germany) | 2024

von Otto-Knapp, R. | Bauer, T. | Brinkmann, F. | +18

3

Tuberculosis Infection Control & Hygiene - Recommendations of the DZK

enthalten in: Pneumologie (Stuttgart, Germany) | 2023

von Witte, P. | Arvand, M. | Barth, S. | +12

4

Long-term multidrug- and rifampicin-resistant tuberculosis treatment outcome by new WHO definitions in Germany

enthalten in: The European respiratory journal | 2022

von Otto-Knapp, R. | Häcker, B. | Krieger, D. | +10

5

Tuberculosis in adulthood - The Sk2-Guideline of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the diagnosis and treatment of adult tuberculosis patients

enthalten in: Pneumologie (Stuttgart, Germany) | 2022

von Schaberg, T. | Brinkmann, F. | Feiterna-Sperling, C. | +17

6

Screening for tuberculosis among refugee children and adolescents from Ukraine - A recommendation of the German Central Committee against Tuberculosis e. V. (DZK) together with the writing group pediatric tuberculosis of the Society of Pediatric Pneumology (GPP)

enthalten in: Pneumologie (Stuttgart, Germany) | 2022

von Brinkmann, F. | Feiterna-Sperling, C. | Günther, A. | +8

7

Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents : implications for diagnosis and treatment

enthalten in: The European respiratory journal | 2022

von Antimycobacterial Susceptibility Testing Group | Georghiou, S. | Rodwell, T. | +98

8

Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents : implications for diagnosis and treatment

enthalten in: The European respiratory journal | April 14, 2022

von Georghiou, S. | Rodwell, T. | Korobitsyn, A. | +124

9

Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest Physicians

enthalten in: Respiration; international review of thoracic diseases | 2022

von Lommatzsch, M. | Rabe, K. | Taube, C. | +20

10

Long-term safety and tolerability of delamanid-containing regimens in MDR- and XDR-TB patients in a specialised tuberculosis treatment center in Berlin, Germany

enthalten in: The European respiratory journal | 2020

von Häcker, B. | Schönfeld, N. | Krieger, D. | +4